NCI sponsored, ECOG-ACRIN Phase 3 Study of Leukine in Combination with Ipilimumab and Nivolumab in Front Line Treatment of Melanoma Heads to Last Stages of Enrollment
Vial Announces Dr. Antoni Ribas of UCLA to Vial Oncology CRO Advisory Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Dr. Antoni Ribas, an immuno-oncology pioneer, has joined Vial s Oncology Scientific Advisory Board. Dr. Ribas, along with other members of the.
/PRNewswire/ Dr. Antoni Ribas, an immuno-oncology pioneer, has joined Vial s Oncology Scientific Advisory Board. Dr. Ribas, along with other members of the.